Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita)

Committee for Guidelines for the Management of Pemphigoid Diseases (Including Epidermolysis Bullosa Acquisita)

Research output: Contribution to journalArticle

Abstract

The pemphigoid group is a category of autoimmune subepidermal blistering diseases in which autoantibodies deposit linearly at the epidermal basement membrane zone (BMZ). The main subtypes of pemphigoid mediated by immunoglobulin G autoantibodies are bullous pemphigoid (BP), mucous membrane pemphigoid (MMP) and epidermolysis bullosa acquisita (EBA). To establish the first guidelines approved by the Japanese Dermatological Association for the management of pemphigoid diseases, the Committee for Guidelines for the Management of Pemphigoid Diseases (Including EBA) was founded as part of the Study Group for Rare Intractable Skin Diseases under the Ministry of Health, Labor and Welfare Research Project on Overcoming Intractable Diseases. These guidelines aim to provide current information for the management of BP, MMP and EBA in Japan. Based on evidence, the guidelines summarize the clinical and immunological manifestations, pathophysiologies, diagnostic criteria, disease severity determination criteria, treatment algorithms and treatment recommendations. Because of the rarity of these diseases, there are few clinical studies with a high degree of evidence, so several parts of these guidelines were established based on the opinions of the Committee. To further optimize these guidelines, periodic revision in line with the new evidence is necessary.

Original languageEnglish
JournalJournal of Dermatology
DOIs
Publication statusAccepted/In press - 2019 Jan 1

Fingerprint

Epidermolysis Bullosa Acquisita
Bullous Pemphigoid
Guidelines
Disease Management
Autoantibodies
Mucous Membrane
Information Management
Skin Diseases
Basement Membrane
Japan
Immunoglobulin G

Keywords

  • autoimmune blistering diseases
  • bullous pemphigoid
  • epidermolysis bullosa acquisita
  • mucous membrane pemphigoid
  • treatment algorithm

ASJC Scopus subject areas

  • Dermatology

Cite this

Committee for Guidelines for the Management of Pemphigoid Diseases (Including Epidermolysis Bullosa Acquisita) (Accepted/In press). Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita). Journal of Dermatology. https://doi.org/10.1111/1346-8138.15111

Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita). / Committee for Guidelines for the Management of Pemphigoid Diseases (Including Epidermolysis Bullosa Acquisita).

In: Journal of Dermatology, 01.01.2019.

Research output: Contribution to journalArticle

Committee for Guidelines for the Management of Pemphigoid Diseases (Including Epidermolysis Bullosa Acquisita) 2019, 'Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita)', Journal of Dermatology. https://doi.org/10.1111/1346-8138.15111
Committee for Guidelines for the Management of Pemphigoid Diseases (Including Epidermolysis Bullosa Acquisita). Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita). Journal of Dermatology. 2019 Jan 1. https://doi.org/10.1111/1346-8138.15111
Committee for Guidelines for the Management of Pemphigoid Diseases (Including Epidermolysis Bullosa Acquisita). / Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita). In: Journal of Dermatology. 2019.
@article{1ccaea70ba75409f9654de68da86aef9,
title = "Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita)",
abstract = "The pemphigoid group is a category of autoimmune subepidermal blistering diseases in which autoantibodies deposit linearly at the epidermal basement membrane zone (BMZ). The main subtypes of pemphigoid mediated by immunoglobulin G autoantibodies are bullous pemphigoid (BP), mucous membrane pemphigoid (MMP) and epidermolysis bullosa acquisita (EBA). To establish the first guidelines approved by the Japanese Dermatological Association for the management of pemphigoid diseases, the Committee for Guidelines for the Management of Pemphigoid Diseases (Including EBA) was founded as part of the Study Group for Rare Intractable Skin Diseases under the Ministry of Health, Labor and Welfare Research Project on Overcoming Intractable Diseases. These guidelines aim to provide current information for the management of BP, MMP and EBA in Japan. Based on evidence, the guidelines summarize the clinical and immunological manifestations, pathophysiologies, diagnostic criteria, disease severity determination criteria, treatment algorithms and treatment recommendations. Because of the rarity of these diseases, there are few clinical studies with a high degree of evidence, so several parts of these guidelines were established based on the opinions of the Committee. To further optimize these guidelines, periodic revision in line with the new evidence is necessary.",
keywords = "autoimmune blistering diseases, bullous pemphigoid, epidermolysis bullosa acquisita, mucous membrane pemphigoid, treatment algorithm",
author = "{Committee for Guidelines for the Management of Pemphigoid Diseases (Including Epidermolysis Bullosa Acquisita)} and Hideyuki Ujiie and Hiroaki Iwata and Jun Yamagami and Takekuni Nakama and Yumi Aoyama and Shigaku Ikeda and Norito Ishii and Keiji Iwatsuki and Michiko Kurosawa and Daisuke Sawamura and Akiko Tanikawa and Daisuke Tsuruta and Wataru Nishie and Wataru Fujimoto and Masayuki Amagai and Hiroshi Shimizu",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/1346-8138.15111",
language = "English",
journal = "Journal of Dermatology",
issn = "0385-2407",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita)

AU - Committee for Guidelines for the Management of Pemphigoid Diseases (Including Epidermolysis Bullosa Acquisita)

AU - Ujiie, Hideyuki

AU - Iwata, Hiroaki

AU - Yamagami, Jun

AU - Nakama, Takekuni

AU - Aoyama, Yumi

AU - Ikeda, Shigaku

AU - Ishii, Norito

AU - Iwatsuki, Keiji

AU - Kurosawa, Michiko

AU - Sawamura, Daisuke

AU - Tanikawa, Akiko

AU - Tsuruta, Daisuke

AU - Nishie, Wataru

AU - Fujimoto, Wataru

AU - Amagai, Masayuki

AU - Shimizu, Hiroshi

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The pemphigoid group is a category of autoimmune subepidermal blistering diseases in which autoantibodies deposit linearly at the epidermal basement membrane zone (BMZ). The main subtypes of pemphigoid mediated by immunoglobulin G autoantibodies are bullous pemphigoid (BP), mucous membrane pemphigoid (MMP) and epidermolysis bullosa acquisita (EBA). To establish the first guidelines approved by the Japanese Dermatological Association for the management of pemphigoid diseases, the Committee for Guidelines for the Management of Pemphigoid Diseases (Including EBA) was founded as part of the Study Group for Rare Intractable Skin Diseases under the Ministry of Health, Labor and Welfare Research Project on Overcoming Intractable Diseases. These guidelines aim to provide current information for the management of BP, MMP and EBA in Japan. Based on evidence, the guidelines summarize the clinical and immunological manifestations, pathophysiologies, diagnostic criteria, disease severity determination criteria, treatment algorithms and treatment recommendations. Because of the rarity of these diseases, there are few clinical studies with a high degree of evidence, so several parts of these guidelines were established based on the opinions of the Committee. To further optimize these guidelines, periodic revision in line with the new evidence is necessary.

AB - The pemphigoid group is a category of autoimmune subepidermal blistering diseases in which autoantibodies deposit linearly at the epidermal basement membrane zone (BMZ). The main subtypes of pemphigoid mediated by immunoglobulin G autoantibodies are bullous pemphigoid (BP), mucous membrane pemphigoid (MMP) and epidermolysis bullosa acquisita (EBA). To establish the first guidelines approved by the Japanese Dermatological Association for the management of pemphigoid diseases, the Committee for Guidelines for the Management of Pemphigoid Diseases (Including EBA) was founded as part of the Study Group for Rare Intractable Skin Diseases under the Ministry of Health, Labor and Welfare Research Project on Overcoming Intractable Diseases. These guidelines aim to provide current information for the management of BP, MMP and EBA in Japan. Based on evidence, the guidelines summarize the clinical and immunological manifestations, pathophysiologies, diagnostic criteria, disease severity determination criteria, treatment algorithms and treatment recommendations. Because of the rarity of these diseases, there are few clinical studies with a high degree of evidence, so several parts of these guidelines were established based on the opinions of the Committee. To further optimize these guidelines, periodic revision in line with the new evidence is necessary.

KW - autoimmune blistering diseases

KW - bullous pemphigoid

KW - epidermolysis bullosa acquisita

KW - mucous membrane pemphigoid

KW - treatment algorithm

UR - http://www.scopus.com/inward/record.url?scp=85075963406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075963406&partnerID=8YFLogxK

U2 - 10.1111/1346-8138.15111

DO - 10.1111/1346-8138.15111

M3 - Article

C2 - 31646663

AN - SCOPUS:85075963406

JO - Journal of Dermatology

JF - Journal of Dermatology

SN - 0385-2407

ER -